Libya vs Turkey: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Libya
92.0%
in 2025
Turkey
92.0%
in 2025
Libya rank
56th
Turkey rank
56th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Libya
- Turkey
How they compare
Libya currently reports 92.0% against 92.0% in Turkey, a difference of 0.0%.
Across all 18 years both countries report, Turkey has been ahead every year.
Libya ranks 56th and Turkey ranks 56th of 194 countries.
Turkey has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 48.5% | 48.5% | Turkey |
| 2010s | 44.6% | 96.4% | 51.8% | Turkey |
| 2020s | 78.8% | 94.5% | 15.7% | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Libya or Turkey?
- Libya, at 92.0% against 92.0% in Turkey as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Libya and Turkey?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Turkey?
- 18 years are reported by both, from 2008 to 2025.
- How do Libya and Turkey rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Libya ranks 56th and Turkey ranks 56th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.